000			01677 a2200445 4500
005			20250516130803.0
264		0	_c20130812
008			201308s 0 0 eng d
022			_a1520-510X
024	7		_a10.1021/ic302219v _2doi
040			_aNLM _beng _cNLM
100	1		_aRuiz, José
245	0	0	_aNovel bis-C,N-cyclometalated iridium(III) thiosemicarbazide antitumor complexes: interactions with human serum albumin and DNA, and inhibition of cathepsin B. _h[electronic resource]
260			_bInorganic chemistry _cJan 2013
300			_a974-82 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xchemical synthesis
650	0	4	_aBinding, Competitive
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCathepsin B _xantagonists & inhibitors
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCrystallography, X-Ray
650	0	4	_aDNA _xchemistry
650	0	4	_aElectrophoresis, Gel, Two-Dimensional
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aIridium _xchemistry
650	0	4	_aOrganometallic Compounds _xchemical synthesis
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aSemicarbazides _xchemical synthesis
650	0	4	_aSerum Albumin _xchemistry
700	1		_aVicente, Consuelo
700	1		_ade Haro, Concepción
700	1		_aBautista, Delia
773	0		_tInorganic chemistry _gvol. 52 _gno. 2 _gp. 974-82
856	4	0	_uhttps://doi.org/10.1021/ic302219v _zAvailable from publisher's website
999			_c22404799 _d22404799